Certificate number:RU.77.99.88.003.E.000703.02.17
Date of registration and renewal:13.02.2017
Dosage form: & nbspTablets weighing 900 mg.
Classification "Composition" & nbsp Supplements - vitamins, vitamin-like substances and coenzymes BAD - vitamin and mineral complexes
Classification "Clinical" & nbsp BAD-sources of multivitamins containing individual minerals and mineral complexes Supplements containing iron Supplements containing iodine Supplements containing zinc, copper, manganese Supplements containing selenium BAA containing fluorine Supplements containing calcium and phosphorus
Composition: & nbspVitamin-mineral premix (MCC, calcium carbonate, ascorbic acid, nicotinamide, iron sulfate, calcium pantothenate, zinc sulfate, biotin, sodium selenate, retinol acetate, pyridoxine hydrochloride, thiamine mononitrate, manganese sulfate, vitamin D3, riboflavin, folic acid, copper sulfate, potassium iodide, sodium fluoride, cyanocobalamin, chromium picolinate, sodium molybdate), calcium carbonate, Fibbrulin Instant (inulin from chicory), dry lactulose "Lactusan", sodium hyaluronate, lactose, zinc citrate, ascorbic acid, vitamin E 50% extract ranata, alimentary gelatin, calcium stearate, L-lipoic acid, coenzyme Q10.
Scope: & nbspFor realization to the population as a biologically active additive to food - an additional source of vitamins A, B1, B2, B6, B12, C, D3, E, PP, biotin, pantothenic acid, folic acid (APPENDIX) and trace elementsiodine, iron, copper, zinc, manganese, chromium, molybdenum, selenium, fluorine), a source of hyaluronic acid, lipoic acid and coenzyme Q10 containing calcium.
Suggested Usage: & nbspAdults take 1 tablet daily with meals or after meals. Duration of admission - 1 month, if necessary, reception can be repeated.
Contraindications:Individual intolerance of dietary supplements, pregnancy, breast-feeding; Conditions in which iodine preparations are contraindicated.
Special instructions:Before use, it is recommended to consult with an endocrinologist.
Shelf life:3 years.
Storage conditions:Store in a dry place inaccessible to children at a temperature not exceeding 25 ° C.
Research protocols:ATreplacing the certificate of state registration No. RU.77.99.88.003.Е.010712.12.15 of 09.12.2015; expert opinions of the Federal Agency for Financial Monitoring and Certification of the Federal Service for Supervision of Consumer Rights Protection of the Russian Federation No. 10-2FTS / 4402 of 06.11.2015, No. 10-2FTS / 4860 of 04.12.2015.
Recipient:Farmatera, Open CompanyFarmatera, Open Company Russian Federation
Information update date: & nbsp02.03.2017
Instructions
Up